INTECH Investment Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Sell
38,994
-29,317
-43% -$366K ﹤0.01% 1412
2025
Q4
$883K Buy
68,311
+15,030
+28% +$193K 0.01% 1197
2025
Q3
$688K Buy
53,281
+6,658
+14% +$89K 0.01% 1394
2025
Q2
$830K Sell
46,623
-7,511
-14% -$131K 0.01% 1314
2025
Q1
$965K Buy
54,134
+28,354
+110% +$644K 0.01% 1218
2024
Q4
$768K Buy
25,780
+3,637
+16% +$77K 0.01% 1308
2024
Q3
$346K Buy
+22,143
New +$402K ﹤0.01% 1434
2023
Q4
Sell
-12,614
Closed -$204K 732
2023
Q3
$204K Sell
12,614
-5,731
-31% -$165K ﹤0.01% 696
2023
Q2
$761K Sell
18,345
-13,663
-43% -$848K 0.01% 520
2023
Q1
$1.92M Buy
32,008
+5,229
+20% +$418K 0.02% 457
2022
Q4
$1.96M Buy
26,779
+24,072
+889% +$1.81M 0.01% 449
2022
Q3
$206K Sell
2,707
-2,338
-46% -$182K ﹤0.01% 648
2022
Q2
$351K Buy
+5,045
New +$380K ﹤0.01% 639

Other funds holding NVCR